Russian Medical Translation Services

Yes. We have experience with Russian Federal Service for Healthcare Supervision submissions and follow the formatting requirements for Russian drug registration dossiers.

Yes. We have the capacity to manage multi-country projects with a single project manager coordinating across all CIS trial sites, ensuring consistent terminology and formatting.

We build client-specific Russian medical glossaries and translation memories at project start. These assets are maintained and updated throughout the project lifetime, ensuring consistency whether the dossier runs to 200 or 2,000 pages.

Yes. Russia's Federal Service for Healthcare Supervision (Roszdravnadzor) and the Eurasian Economic Union (EAEU) pharmaceutical registration framework each have specific Russian-language document structures and terminology conventions. We follow Roszdravnadzor CTD formatting guidance and EAEU TR 043/2017 technical regulations for medical device documentation. Our translators apply the correct official terminology for drug names, dosage units, adverse event classification, and clinical trial phase descriptions throughout.

All translators and project managers sign GDPR-aligned data processing agreements before receiving any patient-identifiable or trial-confidential material. Files are transferred over encrypted channels, processed on secure infrastructure outside Russian jurisdiction, and purged from our systems on project closure unless you request translation memory retention. For projects involving Russian patient data subject to Federal Law 152-FZ (On Personal Data) we flag handling requirements at project start.